Finance

Lists
RNTX:NASDAQ
Rein Therapeutics Inc
0,83 $
+1,09%
(+0,0090) 1D
6 қаз., 12:48:22 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNTX...
Open
0,82 $
High
0,83 $
Low
0,81 $
Mkt. cap
69,41 млн
Avg. vol.
396,51 м.
Volume
91,06 мың
52-wk high
2,18 $
52-wk low
0,69 $
EPS
-1,59 $
Beta
1,36
Shares outstanding
86,27 млн
No. of employees
10
Open
0,82 $
High
0,83 $
Low
0,81 $
Mkt. cap
69,41 млн
Avg. vol.
396,51 м.
Volume
91,06 мың
52-wk high
2,18 $
52-wk low
0,69 $
EPS
-1,59 $
Beta
1,36
Shares outstanding
86,27 млн
No. of employees
10
News stories
From web sources and news partners
About Rein Therapeutics Inc
CEO-
Employees10
Founded2001
HeadquartersОстин, Техас, Америка Құрама Штаттары
Sector-
Websitereintx.com
Analyst ratings
Based on 2 analysts giving stock ratings to RNTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for RNTX in the last 3 months.
Highest
Current 0,83 $
8,00 $ (+859,23%)
Average
6,00 $ (+619,42%)
Lowest
4,00 $ (+379,62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
8,00 $
+859,2%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 $
+379,6%
08/17/2026
Kemp Dolliver
Brookline Capital Markets
Hold
Downgraded
-
-
01/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,68 млн
2,00 млн
3,07 млн
3,64 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,81 млн
1,96 млн
2,16 млн
2,44 млн
Operating expense
5,49 млн
3,96 млн
5,23 млн
6,08 млн
Total operating expenses
5,49 млн
3,96 млн
5,23 млн
6,08 млн
Operating income
-5,49 млн
-3,96 млн
-5,23 млн
-6,08 млн
Other non operating income
-89,00 мың
-20,00 мың
-608,00 м.
-299,00 м.
EBT including unusual items
-5,58 млн
-32,68 млн
-5,84 млн
-6,38 млн
EBT excluding unusual items
-5,58 млн
-3,98 млн
-5,84 млн
-6,38 млн
Income tax expense
-
-712,00 м.
-
-
Effective tax rate
-
2,18%
-
-
Other operating expenses
-
-
-
-
Net income
-5,58 млн
-31,97 млн
-5,84 млн
-6,38 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,49 млн
-3,96 млн
-5,23 млн
-6,08 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары